Important information

Please read this page before proceeding, as it explains certain restrictions imposed by law on the distribution of this information and the countries in which our funds are authorised for sale. It is your responsibility to be aware of and to observe all applicable laws and regulations of any relevant jurisdiction.

By confirming that you have read this important information and the terms and conditions, you also confirm that you agree that such terms and conditions will apply to any subsequent access to the Individual Investors section of this website by you, and that all such subsequent access will be subject to the disclaimers, risk warnings and other information set out herein.

i) you understand this website uses cookies to ensure that we give you the best browsing experience on our website. If you continue browsing, we consider that you accept the use of these cookies. To manage your cookies you can also use our automated/online tool which is available by clicking   located at the bottom right hand side of your screen. View the cookies policy of this website

Legal and Regulatory Information

Accuracy of information; changes

Whilst considerable care has been taken to ensure the information contained within this website is accurate and up-to-date, no warranty, guarantee or representation is given as to the accuracy, reliability or completeness of any information and no liability is accepted for any errors or omissions in such information. The information included on this site has been produced by Capital International Management Company Sàrl (“CIMC”), which is regulated by the Commission de Surveillance du Secteur Financier (“CSSF” – Financial Regulator of Luxembourg) and its affiliates, as appropriate (“Capital Group”). Any reproduction, disclosure or dissemination of these materials by you is prohibited.

Some of the information on this website may contain projections or other forward looking statements regarding future events or future financial performance of countries, markets or companies. These statements are only predictions, opinions or estimates made on a general basis and actual events or results may differ materially. No information on this site constitutes investment, tax, legal or any other advice.

All investment strategies, products and services referred to on this website are subject to change without notice. Capital Group may amend the website (including this Legal Information section) and our investment strategies, products and services at any time with or without notice to the user. Capital Group is under no obligation to update the website or to correct inaccuracies which may become apparent. Capital Group shall have no liability for any direct, indirect, consequential or special losses or damages of any kind whatsoever arising from or in connection with any use of the website or its contents.

No information, whether oral or written, obtained by you through or from this site or from any conversation with Capital Group staff or a professional consultant will have the effect of varying this Legal Information.

Not an offer

This website (and the information contained therein) is provided for information purposes only, and does not constitute either an offer, invitation, inducement or a solicitation to buy or sell any securities or investment product nor is it a recommendation for any security or investment product. The information contained on this website is not directed at or intended for distribution to, or use by, any person in any jurisdiction or country where such use or distribution would be contrary to any applicable local law or regulation or would subject Capital Group to any registration or licensing requirement in such jurisdiction. It is your responsibility to inform yourself of any applicable legal and regulatory restrictions and to ensure that your access and use of this information does not contravene any such restrictions and to observe all applicable laws and regulations of any relevant jurisdiction. Professional advice should be sought in cases of doubt, as any failure to do so may constitute a breach of the securities laws in any such jurisdiction.

.Potential investors should read the terms and conditions in the relevant offering materials carefully before any investment is made. Investors should be aware that this website may not provide all the information which is necessary or desirable to make such a decision and should undertake their own due diligence.

The funds referred to herein are offered, as part of a formal process, by their current prospectuses only. The prospectuses and key investor information documents contain more complete information about these funds and should be read carefully in conjunction with the latest annual and semi-annual reports before investing. Depending on the countries where the funds are offered, the prospectuses are supplemented by an addendum containing supplementary information required by the regulations of such jurisdictions. However, prospectuses and other information relating to these funds will not be distributed to persons in any country where such distribution would be contrary to local law or regulation. Capital Group will not at any time be arranging on behalf of the individual investor.
The contents of this website have been approved by Capital International Management Company Sàrl and is only to be accessed and viewed by (and the investment opportunities described in it are only available to) limited categories of persons in the UK and in other jurisdictions.

The funds referred to on the website are Luxembourg-registered UCITS, which are registered in each of the relevant jurisdictions under the applicable local laws and regulations. Investors should be aware that protections provided by relevant local laws and regulations may not apply to investment in the funds. It is your responsibility to be aware of the applicable laws and regulations of your country of residence. In particular, UK investors should note that holdings or investments in the funds will not be covered under UK Financial Services Compensation Scheme. Investors will have no right of cancellation under FCA’s Cancellation and Withdrawal rules.

The funds referred to herein are not registered under the United States Investment Company Act of 1940 and securities issued by the funds are not registered under the United States Securities Act of 1933. This is not an offer to sell, nor a solicitation of an offer to buy, the securities of any fund in the United States, its territories, possessions or protectorates under its jurisdiction nor to nationals, citizens or residents in any one of those areas.

Capital Group will not regard any person who accesses this website as its client in relation to any of the investment products or services detailed in the website, unless expressly agreed. Capital Group will not be responsible to any individual for providing them the same protections as are offered to its clients. Capital Group shall not be undertaking arranging activities at any time on the behalf of individuals electing to access the website.

No investment advice

The website is provided for information purposes only. Nothing on this website will constitute legal, tax or investment advice or recommendations. The products described may not be available to, or suitable for, all investors. In addition, current levels, bases and reliefs from tax depend on individual circumstances, which may also change in the future. Investors should not invest in the funds unless they understand its nature and the extent of their exposure to risk. Independent professional advice from a suitable authorised person, including tax advice, should be sought before making an investment decision.

Investment risk

The value of any investment made in the funds or otherwise and the income from such can go down as well as up, and the investor may not get back the full amount invested. Past performance is not a guarantee of future returns. Changes in the rate of exchange may also cause the value of overseas investments to go up or down. Funds that invest in asset classes carrying greater risk, such as emerging markets, high yield securities and securities of small capitalisation companies may have a higher risk of loss of capital.

Third party websites

Capital Group accepts no responsibility for any information contained in any website accessed via a hyperlink from this website. No other person/company may link their website into Capital Group's website without the express written permission of Capital Group. The content, accuracy and opinions expressed in such websites are not checked, analysed, monitored or endorsed by us. Access to any third party website is at the user’s own risk.

Third party content

Materials and information distributed by Capital Group, whether in hard copy, website or electronic format, include general news and information, commentary, interactive tools, quotes, research reports and data concerning the financial markets, securities and other subjects. Some of this content is supplied by third parties ("Third Party Content") that are not affiliated with Capital Group (each a "Third Party Content Provider"). Third Party Content is being provided for non-commercial purposes only and may not be copied, used or distributed without the permission of the relevant Third Party Content Provider. Third Party Content may be protected by United States or international copyrights. Third Party Content may not be copied, used or distributed without the permission of the relevant Third Party Content Provider. All trademarks and service marks appearing on this site are the exclusive property of their respective owners. These provisions are not intended to, and will not, transfer or grant any rights in or to the Third Party Content, and the relevant Third Party Content Provider reserves all such rights. Capital Group's use of any Third Party Content is not intended to imply that any Third Party Content Provider sponsors, endorses, sells or promotes any Capital Group investment strategies, products or services. Third Party Content is provided on an "AS IS" basis and Third Party Content Providers shall have no liability for monetary damages on account of the Third Party Content provided herein.

Enforcement of terms and conditions

These terms and conditions are governed and interpreted pursuant to the laws of the Grand Duchy of Luxembourg. If any part of these terms and conditions is deemed to be unlawful, void or unenforceable, that part will be deemed severable and will not affect the validity and enforceability of the remaining provisions. None of these terms and conditions are enforceable under the Contracts (Rights of Third Parties) Act 1999 by a person who is not a party to its terms.

Switzerland Only 

Capital International Sàrl is responsible for the content of this website in Switzerland.
The Funds listed on this website are authorized by the Swiss Financial Market Authority (FINMA) for distribution in or from Switzerland. Capital International Sàrl, 3 Place des Bergues, 1201 Geneva, is the Funds’ Representative in Switzerland and JPMorgan (Suisse) SA, 8 rue de la Confédération, 1204 Geneva, acts as their Swiss Paying Agent. The prospectus, the key investor information documents, the articles of incorporation, the latest annual and semi-annual reports of the Fund can be obtained through this website and upon request free of charge from the Swiss Representative.

Cookies

This site uses cookies. The cookies we use are to help make the website more user-friendly. You are not required to accept cookies, and you may delete and block cookies from this site. To find out more about cookies on this website and how to delete cookies, see our cookie policy.

I have read and accept the terms and conditions of this site.

Capital IdeasTM

Investment insights from Capital Group

Categories
Technology & Innovation
The Long View: Four megatrends to watch
Mark L. Casey
Equity Portfolio Manager
Rich Wolf
Equity Portfolio Manager
Brad Freer
Portfolio Manager
Gigi Pardasani
Investment Analyst

Innovation is not just a buzzword — it is the lifeblood of investment success. It fuels growth, drives competitiveness and shapes the future of companies. But while innovation is essential, not all emerging trends are created equal.


That’s why our portfolio managers and analysts are scouring the world for enduring trends that have the potential to transcend individual sectors and impact the broader investing landscape for years to come. Here are four megatrends our investment teams are closely watching.


1. AI revolution will reshape many industries


Mark Casey, equity portfolio manager


Artificial intelligence has captured the imaginations of investors in tech companies, but the use of AI will likely extend well beyond generative chatbots and have lasting impacts across many industries. As interesting as I find large language models like ChatGPT, I suspect AI-powered robots could have an even bigger economic impact over the next decade — with their applications used everywhere from homes to factories to hospitals.


For example, when Amazon started working on robots to select items and put them in shipping boxes, failure rates were high and successful picks took up to two minutes each. Seven years later, the company’s new “Sparrow” robot can pick and pack two-thirds of the 100 million products in a typical Amazon warehouse, needing just seconds for each. Delivery drones and driverless taxis are more visible examples of AI-enabled robots being tested in select cities across the globe. And in health care, companies are pairing AI with robotics to improve the success of surgeries and diagnostics.


Collaborative robots are a small but rapidly growing part of industry

This bar chart is labeled, “Annual installation of new industrial robots (‘000 units)” and visualizes the number of new industrial robot installations from 2017 to 2026. It distinguishes between traditional robots and collaborative robots from 2017 to 2022. The y-axis represents the number of installations in thousands, while the x-axis represents the years. The number of collaborative and traditional robots from 2017 to 2022 are as follows: In 2017, there were 11k collaborative robots and 389k traditional robots; in 2018 there were 19k collaborative and 405k traditional; in 2019 there were 21k collaborative and 366k traditional; in 2020 there were 26k collaborative and 363k traditional; in 2021 there were 42k collaborative and 484k traditional; and in 2022 there were 55k collaborative and 498k traditional. There is a caption that shows that there was a 31% growth in collaborative robot installations between 2021 and 2022. Additionally, there are forecasts for the total number of industrial robots from 2023 to 2026. The forecast is for 593k robots in 2023, 622k in 2024, 662k in 2025, and 718k in 2026.

Source: International Federation of Robotics, World Robotics 2023. A collaborative robot is an industrial robot that can safely operate alongside humans in a shared workspace. In contrast, traditional robots are hard coded to repeatedly perform one task, work independently and remain stationary. Forecast includes collaborative and traditional robots.

Early stock market winners in the field of AI have been concentrated in the tech industry, particularly in sub-sectors like semiconductors, cloud infrastructure and software. Companies that benefit most from advances in robotics may be spread over a broader set of industries. I want to invest in companies at the forefront of using advanced robots to improve client experiences, efficiency and profitability.


2. Health care innovation is leading to breakthroughs beyond obesity drugs


—Rich Wolf, equity portfolio manager


While obesity drugs have garnered most of the headlines, we are currently in an era of innovation across the health care landscape. Companies are actively pursuing therapies and technologies to treat — and possibly cure — major diseases and improve people’s lives.


One rapidly advancing field is cell therapy, which involves modifying cells outside the body and then infusing them into patients. This approach has gained approval for use against certain blood cancers that previously offered few treatment options. Companies are now developing cell therapies for diabetes, liver disease and heart failure.


New gene therapies are also providing opportunities for many pharma and biotech firms. Alnylam Pharmaceuticals, for example, is leading the way in gene “silencing” techniques like RNAi that can selectively suppress genes associated with certain diseases. Additionally, the progress in gene editing systems, such as CRISPR, is particularly interesting. Boston-based Vertex Pharmaceuticals achieved a significant milestone, becoming the first company to receive approval for a CRISPR-based therapy to treat sickle cell disease.


Robust pipelines could lead to new era of drug discovery

The chart titled, “Top pharmaceutical companies worldwide, by number of drugs in R&D pipeline” ranks the leading pharmaceutical companies based on the number of drugs in their research and development (R&D) pipelines. Roche occupies the top position with 194. Novartis follows with 191. The subsequent companies in descending order of R&D pipeline size are Takeda (178), Bristol Myers Squibb (175), Pfizer (171), Johnson & Johnson (156), AstraZeneca (155), Merck (151), Sanofi (145) and Eli Lilly (135). Significant hurdles remain for widespread adoption of these technologies, and not all innovations will

Source: Statista. As of January 2023.

Significant hurdles remain for widespread adoption of these technologies, and not all innovations will succeed. But the future of health care is exciting, and the potential for value creation over the next decade appears promising.


3. Shifting trade winds bring opportunities to new markets


—Brad Freer, equity portfolio manager


I will be watching and investing around shifts in global trade and supply chains in the years to come. Rising geopolitical tensions and logistical issues during the COVID pandemic forced many companies to adopt a “China Plus One” strategy, diversifying their supply chains out of China. This has resulted in emerging markets like India, Southeast Asia and Latin America benefiting from new trade partners and opportunities.


I believe this trend will continue to grow, with Mexico being a prime beneficiary of nearshoring. During my recent trip to Monterrey and Tijuana, I witnessed multinational companies like Carrier and Kia building factories to take advantage of the low-cost and efficient labor force. These multi-million-square-foot facilities with their thousands of workers reminded me of the early days of China’s manufacturing boom.


As companies diversify supply chains, new winners will emerge

The chart depicts a map titled, “Top destinations for companies redirecting investments from China.” It highlights China and features arrows pointing toward five regions: Southeast Asia, the United States, Mexico, Europe and India. Each arrow is labeled with the percentage of companies surveyed that listed a region as a destination it would redirect investments from China. 57% of companies listed Southeast Asia; 30% listed the United States; 29% listed Mexico; 23% listed Europe; and 22% listed India.

Source: AmCham Shanghai 2023 China Business Report, published September 19, 2023. Based on a survey of 325 foreign companies doing business in China. Of those companies, 40% said they were redirecting investments from China to other locations, including Southeast Asia, the United States, Mexico, Europe and India, among others. Survey respondents could provide multiple responses, so total does not add up to 100%.

I’ll be looking to invest in businesses that could benefit from this change. For example, construction and materials companies will be needed to build new facilities. Real estate developers, who are getting their pick of customers in many locations, also appear attractive. And finally, nimble multinationals that embrace supply chain diversification may gain an edge over competitors not able to adapt as quickly.


4. Cultivating innovation across the agricultural landscape


—Gigi Pardasani, equity investment analyst


The world’s food system is undergoing an exciting transformation. Companies are exploring innovative solutions to revolutionise agriculture and the industries it impacts. One trend I’m following is precision agriculture — which is essentially the use of high-tech tools to grow crops more efficiently.


Farmers armed with cutting-edge technology using machine learning, geolocation and sensors are able to make smarter decisions in the field. Those who have already embraced precision agriculture have seen up to 30% greater productivity through a reduction in the number of passes on the field and improved soil. Real-time data has been a game changer, with many farmers becoming increasingly reliant on analytics and visualisations to improve their processes. Artificial intelligence could further drive improvements. While this latest technology clearly benefits agricultural machinery companies, it should also have environmental and productivity benefits for a host of other businesses.


Who’s innovating in agriculture?

The chart provides examples of companies actively involved in six current agricultural trends: 1) Precision agriculture: This category includes companies like Deere, Trimble and Bayer; 2) Regenerative farming: Nestlé, General Mills and PepsiCo; 3) “Green fertilizers”: Yara International, CF Industries and OCI; 4) Seed innovation: Bayer and BASF; 5) Alternative proteins: Tyson/Protix, Ajinomoto and Beyond Meat; 6) Waste management: Ocado Group and Darling Ingredients.

Source: Capital Group, as of March 2024. The graphic is a non-exhaustive list provided by analysts of companies working on these trends. These examples are not based on holdings or recommendations and are for illustrative purposes only.

From seed innovation to regenerative farming and even alternative proteins, the industry is evolving. The agricultural cycle can require patience, but the developments are promising. I believe these are multi-year shifts that long-term investors should have on their radar.


Patience is a virtue — and a sound investment strategy


—Peter Eliot, equity portfolio manager


Most of us spend our time worrying about the short-term. Our daily routines often revolve around things like planning our day, shuttling kids to and from school, completing the next work task, or tracking stock market fluctuations.


But in investing, it’s usually better to think long term. Investors often lack the patience required to capitalise on megatrends as these don’t develop in a straight line, and the market’s attention can be diverted by the latest fad. Self-driving cars, for example, once garnered the same enthusiasm that AI currently does. But the market has gone through a period of disappointment because the technology has taken awhile to develop, even as the underlying fundamentals haven’t really changed.


Reflecting on my career, I've done a lot of work analysing the outcome of my investment decisions. I’ve found that it really comes down to something very simple: My big mistakes were a failure of patience, and my big successes were a triumph of patience.



Mark L. Casey is an equity portfolio manager with 23 years of investment industry experience (as of 12/31/2023). He holds an MBA from Harvard and a bachelor’s degree from Yale.

Rich Wolf is an equity portfolio manager. He also has equity investment analyst responsibilities covering U.S. medical technology companies and REITs. He holds a PhD from the California Institute of Technology and a bachelor's degree from Princeton.

Bradford F. Freer is an equity portfolio manager with 33 years of investment industry experience (as of 12/31/2023). He holds a bachelor’s degree in international relations from Connecticut College and is a CFA® charterholder.

Gigi Pardasani is an equity investment analyst with responsibilities for large cap industrials. She has 12 years of investment experience and has been with Capital for six years (as of 12/31/22). She holds an MBA from Wharton and a bachelor’s from Harvard.


Past results are not predictive of results in future periods. It is not possible to invest directly in an index, which is unmanaged. The value of investments and income from them can go down as well as up and you may lose some or all of your initial investment. This information is not intended to provide investment, tax or other advice, or to be a solicitation to buy or sell any securities.

Statements attributed to an individual represent the opinions of that individual as of the date published and do not necessarily reflect the opinions of Capital Group or its affiliates. All information is as at the date indicated unless otherwise stated. Some information may have been obtained from third parties, and as such the reliability of that information is not guaranteed.

Capital Group manages equity assets through three investment groups. These groups make investment and proxy voting decisions independently. Fixed income investment professionals provide fixed income research and investment management across the Capital organization; however, for securities with equity characteristics, they act solely on behalf of one of the three equity investment groups.